As we come together to support charitable groups on #GivingTuesday, we hope that you will think of cancer's youngest victims and their loved ones who are suffering through a devastating diagnosis. Neuroblastoma is the most common cancer in infants, outpacing leukemia. In its most aggressive forms, patients must undergo powerful chemotherapy treatments, radiation, stem cell transplant and antibody therapy that can cause a lifetime of after-effects. Yet, life-saving research and clinical trials to fight childhood cancers receive a fraction of the public and private funding that adult cancers do.

On #GivingTuesday, we hope that you will stand with us and help fund a cure. The Children's Neuroblastoma Cancer Foundation has awarded more $2.5 million for neuroblastoma research and clinical trials, and we are making a difference. We know that a lot of charities will be competing for your attention this holiday season. But what could be more gratifying than saving a child's life?

Spread the word and help us eradicate this deadly disease that is threatening our children's futures.